The current study shows that pathogenic variants in the RPE65 gene contribute significantly to the pathogenesis of IRDs and comprise 5.3% of all patients with a confirmed molecular genetic diagnosis. This evidence concerns the gene RPE65 and respiratory distress syndrome in premature infants.